News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Keyes Jason A
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/07/2023 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Granted 125,000 options to buy
@ $3.86, valued at
$482.5k
|
|
01/04/2023 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Granted 4,444 shares
@ $1.19, valued at
$5.3k
Granted 175,000 options to buy
@ $1.06, valued at
$185.5k
|
|
08/30/2022 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Sold 7,000 shares
@ $2.83, valued at
$19.8k
|
|
06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2022 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Sold 5,000 shares
@ $2.52, valued at
$12.6k
|
|
04/05/2022 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Sold 8,000 shares
@ $3.18, valued at
$25.4k
|
|
12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/29/2021 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Sold 8,000 shares
@ $6.7405, valued at
$53.9k
|
|
07/28/2021 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Sold 5,000 shares
@ $5.717, valued at
$28.6k
|
|
06/14/2021 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Granted 5,535 shares
@ $2.35, valued at
$13k
|
|
05/28/2021 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Sold 5,000 shares
@ $6.4967, valued at
$32.5k
|
|
05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2021 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Granted 100,000 options to buy
@ $5.03, valued at
$503k
|
|
12/28/2020 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Sold 8,000 shares
@ $4.7392, valued at
$37.9k
|
|
12/11/2020 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Acquired 5,362 shares
@ $2.35, valued at
$12.6k
|
|
06/12/2020 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Acquired 5,014 shares
@ $2.41, valued at
$12.1k
|
|
05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/24/2020 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Disposed/sold 70,000 options to buy
@ $7.16, valued at
$501.2k
Granted 70,000 options to buy
@ $2.45, valued at
$171.5k
Disposed/sold 90,000 options to buy
@ $4.75, valued at
$427.5k
Granted 90,000 options to buy
@ $2.45, valued at
$220.5k
|
|
02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/19/2020 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Sold 5,000 shares
@ $5.0275, valued at
$25.1k
|
|
01/22/2020 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Sold 5,000 shares
@ $4.4086, valued at
$22k
|
|
12/12/2019 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Granted 90,000 options to buy
@ $4.75, valued at
$427.5k
|
|
09/04/2019 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Sold 5,000 shares
@ $3.5961, valued at
$18k
|
|
08/05/2019 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Sold 5,000 shares
@ $3.9882, valued at
$19.9k
|
|
02/15/2019 |
4
| Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns:
| Granted 70,000 options to buy
@ $7.16, valued at
$501.2k
|
|
10/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/14/2016 |
4
| Keyes Jason A (SVP, CFO) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns:
| Granted 131,250 options
@ $4.02, valued at
$527.6k
Granted 26,250 options
@ $4.02, valued at
$105.5k
Granted 78,750 options
@ $15, valued at
$1.2M
Granted 15,750 options
@ $15, valued at
$236.3k
|
|
|
|